Cidara Therapeutics, Inc. — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2021-09-01

Reporting Person: Shah Preetam (CFO & CBO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-01	Stock Option (right to buy)	$2.22	A	311850	Acquired	2031-08-31	Common Stock (311850.0)	Direct
2021-09-01	Restricted Stock Unit	$	A	50000	Acquired	2022-09-30	Common Stock (50000.0)	Direct

Footnotes

F1: 25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of September 1, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter,such that all shares will be vested on September 1, 2025.

F2: Restricted stock units convert into common stock on a one-for-one basis.

F3: The RSU will fully vest upon the completion of certain corporate milestones on or before September 30, 2022.